The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosis
Abstract
Interferon‐β decreases the relapse rate, relapse severity, progression of neurological disability, and development of new brain lesions observed with brain magnetic resonance imaging in relapsing‐remitting multiple sclerosis patients. The mechanism of action of this effect is presently unknown. This study was based on the hypothesis that immunoregulatory effects of interferon‐β may underlie its demonstrated clinical efficacy. The objective of the study was to determine the effect of interferon‐β‐1a on the expression of interleukin‐10, a cytokine that strongly inhibits cell‐mediated immune responses. Interferon‐β‐1a induced accumulation of interleukin‐10 messenger RNA and protein secretion by cultured peripheral blood mononuclear cells. The observed in vitro effects were similar for healthy control subjects and multiple sclerosis patients. Intramuscular injections of interferon‐β‐1a increased serum levels of interleukin‐10 at 12 and 24 hours following the injection. Greater increases were induced with 12 × 10 6‐IU than 6 × 10 6‐IU injections. The effect of interferon‐β‐1a was relatively specific for interleukin‐10, as treatment with interferon‐β‐1a did not result in accumulation of transforming growth factor‐β messenger RNA. Upregulation of interleukin‐10 represents a possible mechanism of action of interferon‐β's therapeutic effect in relapsing‐remitting multiple sclerosis, and has implications for therapy of other autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Cited by
Immunomodulatory functions of type I interferons
González-Navajas, J. M., Lee, J., David, M., & Raz, E. (2012) · Nature Reviews Immunology · doi:10.1038/nri3133 · Cited by 1,011
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V, Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751
Randomized, comparative study of interferon β-1a treatment regimens in MS: The EVIDENCE Trial
Panitch, H., Goodin, D. S., Francis, G., Chang, P., Coyle, P. K., O’Connor, P., Monaghan, E., Li, D., & Weinshenker, B. (2002) · Neurology · doi:10.1212/01.wnl.0000034080.43681.da · Cited by 635
Hohlfeld, R. (1997) · Brain · doi:10.1093/brain/120.5.865 · Cited by 365
Csuka, E., Morganti-Kossmann, M. C., Lenzlinger, P. M., Joller, H., Trentz, O., & Kossmann, T. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00148-4 · Cited by 324
Metadata
- Authors
- Rudick, R. A., Ransohoff, R. M., Peppler, R., Medendorp, S. V., Lehmann, P., & Alam, J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1996-10
- Volume
- 40
- Issue
- 4
- Pages
- 618-627
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2110812724
- Cited by
- 237
- References
- 2
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosis. https://app.cochat.ai/papers/10.1002/ana.410400412
- The paper
- Rudick, R. A., Ransohoff, R. M., Peppler, R., Medendorp, S. V., Lehmann, P., & Alam, J. (1996). Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.410400412
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.